Skip to main content
Metronomic capecitabine+pyrotinib shows clinical benefits in HER2+ metastatic BC in phase 2
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Metronomic capecitabine+pyrotinib shows clinical benefits in HER2+ metastatic BC in phase 2
User login
Username
Password
Reset your password
Concept
Lead
score
Advanced and Metastatic Breast Cancer
1
1
HER2-Positive Breast Cancer
0
0.95
Breast
0
0.71
Breast Cancer
0
0.85
Cancer
0
0.47
Genomic Medicine
0
0.39
Epidermal Growth Factor Receptor
0
0.33
Specialty
Lead
score
Hematology-Oncology
1
1
Ob/Gyn & Women's Health
0
1
Family Medicine/Primary Care
0
0.44
Edit Tags